Big Pharma money is skewing research

'Endemic financial entanglement' needs to end, say researchers in BMJ
Big pharma money

Drug company financing of research is distorting medical evidence, harming patients and wasting money — and it’s time for it to end, according to a group of international researchers. 

Led by Australian campaigner and Bond University Associate Professor Ray Moynihan, the group are spearheading a BMJ campaign to encourage independence between Big Pharma and medical research.